Zacks Research Issues Negative Estimate for IRWD Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research reduced their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst R. Department now anticipates that the biotechnology company will earn $0.01 per share for the quarter, down from their previous […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research reduced their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst R. Department now anticipates that the biotechnology company will earn $0.01 per share for the quarter, down from their previous […]
